Association of HbA1c and cardiovascular and renal disease in an adult Mediterranean population

BMC Nephrology

Volumn 14, Issue 1, 2013, Pages

  Hernandez, Domingo ^a   Espejo Gil, Ana ^a   Bernal Lopez, M Rosa ^b,c   Mancera Romero, Jose ^d   Baca Osorio, Antonio J ^d   Tinahones, Francisco J ^b,c   Armas Padron, Ana M ^e   Ruiz Esteban, Pedro ^a   Torres, Armando ^f   Gomez Huelgas, Ricardo ^a,c  

^a HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

^b HOSPITAL UNIVERSITARIO VIRGEN DE LA VICTORIA   (Spain)

^c Instituto de Salud Carlos III   (Spain)

^d Ciudad Jardín Health Center   (Spain)

^e Health Care la Cuesta   (Spain)

^f HOSPITAL UNIVERSITARIO DE CANARIAS   (Spain)

Author keywords

Cardiovascular disease; Chronic kidney disease; Glycated hemoglobin

Indexed keywords

CREATININE; GLUCOSE; HEMOGLOBIN A1C; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; BIOLOGICAL MARKER; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN;

ADULT; AGED; ALBUMINURIA; ARTICLE; BLOOD SAMPLING; BODY MASS; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DIET RESTRICTION; DISEASE ASSOCIATION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; RECEIVER OPERATING CHARACTERISTIC; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SPAIN; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; URINALYSIS; ADOLESCENT; BLOOD; CARDIOVASCULAR DISEASES; KIDNEY DISEASES; METABOLISM; MIDDLE AGED; RANDOMIZED CONTROLLED TRIAL; SOUTHERN EUROPE; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; KIDNEY DISEASES; MALE; MEDITERRANEAN REGION; MIDDLE AGED; SPAIN; YOUNG ADULT;

EID: 84880183237     PISSN: None     EISSN: 14712369     Source Type: Journal    
DOI: 10.1186/1471-2369-14-151     Document Type: Article

References (29)

1. International comparison of the relationship of chronic kidney disease prevalence and ESRD risk. Hallan SI, Coresh J, Astor BC, Asberg A, Powe NR, Romundstad S, Hallan HA, Lydersen S, Holmen J, J Am Soc Nephrol 2006 17 2275 2284 10.1681/ASN.2005121273 16790511
2. Prevalence of chronic kidney disease in US adults with undiagnosed diabetes or prediabetes. Plantinga LC, Crews DC, Coresh J, Miller ER 3rd, Saran R, Yee J, Hedgeman E, Pavkov M, Eberhardt MS, Williams DE, Powe NR, Clin J Am Soc Nephrol 2010 5 673 682 10.2215/CJN.07891109 20338960
3. Dysglycemia predicts cardiovascular and kidney disease in the Kidney early evaluation Program. Whaley-Connell A, Pavey BS, McCullough PA, Saab G, Li S, McFarlane SI, Chen SC, Vassalotti JA, Collins AJ, Bakris G, Sowers JR, J Clin Hypertens (Greenwich) 2010 12 51 58 10.1111/j.1751-7176.2009.00190.x
4. Metabolic syndrome and the risk for chronic kidney disease among non-diabetic adults. Kurella M, Lo JC, Chertow GM, J Am Soc Nephrol 2005 16 2134 2140 10.1681/ASN.2005010106 15901764
5. Clinical value of the metabolic syndrome for long term prediction of total and cardiovascular mortality: prospective, population based cohort study. Sundström J, Risérus U, Byberg L, Zethelius B, Lithell H, Lind L, BMJ 2006 332 7546 78 82
6. Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in nondiabetic European men and women. Hu G, Qiao Q, Tuomilehto J, Balkau B, Borch-Johnsen K, Pyorala K, Arch Intern Med 2004 164 1066 1076 10.1001/archinte.164.10.1066 15159263
7. Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus. Selvin E, Marinopoulos S, Berkenblit G, Rami T, Brancati FL, Powe NR, Golden SH, Ann Intern Med 2004 141 421 431 10.7326/0003-4819-141-6- 200409210-00007 15381515
8. Association of hemoglobin A1c with cardiovascular disease and mortality in adults: the European prospective investigation into cancer in Norfolk. Khaw KT, Wareham N, Bingham S, Luben R, Welch A, Day N, Ann Intern Med 2004 141 413 420 10.7326/0003-4819-141-6-200409210-00006 15381514
9. Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults. Selvin E, Steffes MW, Zhu H, Matsushita K, Wagenknecht L, Pankow J, Coresh J, Brancati FL, N Engl J Med 2010 362 800 811 10.1056/NEJMoa0908359 20200384
10. A1C variability predicts incident cardiovascular events, microalbuminuria, and overt diabetic nephropathy in patients with type 1 diabetes. Wadén J, Forsblom C, Thorn LM, Gordin D, Saraheimo M, Groop PH, Diabetes 2009 58 2649 2655 10.2337/db09-0693 19651819
11. Poor glycemic control in diabetes and the risk of incident chronic kidney disease even in the absence of albuminuria and retinopathy: Atherosclerosis Risk in Communities (ARIC) Study. Bash LD, Selvin E, Steffes M, Coresh J, Astor BC, Arch Intern Med 2008 168 2440 2447 10.1001/archinte.168.22.2440 19064828
12. Glycated hemoglobin and the risk of kidney disease and retinopathy in adults with and without diabetes. Selvin E, Ning Y, Steffes MW, Bash LD, Klein R, Wong TY, Astor BC, Sharrett AR, Brancati FL, Coresh J, Diabetes 2011 60 298 305 10.2337/db10-1198 20978092
13. The relationship between dysglycaemia and cardiovascular and renal risk in diabetic and non-diabetic participants in the HOPE study: a prospective epidemiological analysis. Gerstein HC, Pogue J, Mann JF, Lonn E, Dagenais GR, McQueen M, Yusuf S, Diabetologia 2005 48 1749 1755 10.1007/s00125-005-1858-4 16059716
14. Lower estimated glomerular filtration rate and higher albuminuria are associated with all-cause and cardiovascular mortality, A collaborative meta-analysis of high-risk population cohorts. van der Velde M, Matsushita K, Coresh J, Astor BC, Woodward M, Levey A, de Jong P, Gansevoort RT, Kidney Int 2011 79 1341 1352 10.1038/ki.2010.536 21307840
15. Prevalence of obesity in south-east Spain and its relation with social and health factors. Soriguer F, Rojo-Martínez G, Esteva De Antonio I, Ruiz De Adana MS, Catalá M, Merelo MJ, Beltrán M, Tinahones FJ, Eur J Epidemiol 2004 19 33 40 15012020
16. Prevalence of cardiovascular risk factors in an urban adult population from southern Spain. IMAP Study. Gomez-Huelgas R, Mancera-Romero J, Bernal-Lopez MR, Jansen-Chaparro S, Baca-Osorio AJ, Toledo E, Perez-Gonzalez R, Guijarro-Merino R, Tinahones FJ, Martinez-Gonzalez MA, Int J Clin Pract 2011 65 35 40 21192342
17. HbA(1c) in adults without known diabetes from southern Europe, impact of the new diagnostic criteria in clinical practice. Bernal-Lopez MR, Santamaría-Fernandez S, Lopez-Carmona D, Tinahones FJ, Mancera-Romero J, Peña-Jimenez D, Jansen-Chaparro S, Baca-Osorio AJ, Cuesta-Muñoz AL, Serrano-Rios M, Gomez-Huelgas R, Diabet Med 2011 28 1319 1322 10.1111/j.1464-5491.2011.03317.x 21966956
18. Glycated hemoglobin standardization-National Glycohemoglobin Standardization Program (NGSP) perspective. Little RR, Clin Chem Lab Med 2003 41 1191 1198 14598869
19. Diagnosis and classification of Diabetes Mellitus. American Diabetes Association, Diabetes Care 2010 34 Suppl 1 62 S69
20. CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration), A new equation to estimate glomerular filtration rate. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J, Ann Intern Med 2009 150 604 612 10.7326/0003-4819-150-9-200905050- 00006 19414839
21. Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Levey AS, Eckardt KU, Tsukamoto Y, Levin A, Coresh J, Rossert J, De Zeeuw D, Hostetter TH, Lameire N, Eknoyan G, Kidney Int 2005 67 2089 2100 10.1111/j.1523-1755.2005. 00365.x 15882252
22. A catalogue of reporting guidelines for health research. Simera I, Moher D, Hoey J, Schulz KF, Altman DG, Eur J Clin Invest 2010 40 1 35 53 10.1111/j.1365-2362.2009.02234.x 20055895
23. Glycemic status and development of kidney disease: the Framingham heart study. Fox CS, Larson MG, Leip EP, Meigs JB, Wilson PW, Levy D, Diabetes Care 2005 28 2436 2440 10.2337/diacare.28.10.2436 16186276
24. Insulin resistance and risk of chronic kidney disease in nondiabetic US adults. Chen J, Muntner P, Hamm LL, Fonseca V, Batuman V, Whelton PK, He J, J Am Soc Nephrol 2003 14 469 477 10.1097/01.ASN.0000046029.53933.09 12538749
25. Glycated haemoglobin levels are related to chronic subclinical inflammation in renal transplant recipients without pre-existing or new onset diabetes. Porrini E, Gomez MD, Alvarez A, Cobo M, Gonzalez-Posada JM, Perez L, Hortal L, García JJ, Dolores Checa M, Morales A, Hernández D, Torres A, Nephrol Dial Transplant 2007 22 1994 1999 10.1093/ndt/gfm067 17395658
26. Type 1 diabetes increases the expression of proinflammatory cytokines and adhesion molecules in the artery wall of candidate patients for kidney transplantation. Triñanes J, Salido E, Fernández J, Rufino M, González-Posada JM, Torres A, Hernández D, Diabetes Care 2012 35 427 433 10.2337/dc11-1665 22210567
27. Advanced glycation end products and vascular inflammation: implications for accelerated atherosclerosis in diabetes. Basta G, Schmidt AM, De Caterina R, Cardiovasc Res 2004 63 582 592 10.1016/j.cardiores.2004.05.001 15306213
28. Acute intensive insulin therapy exacerbates diabetic blood-retinal barrier breakdown via hypoxia-inducible factor-1alpha and VEGF. Poulaki V, Qin W, Joussen AM, Hurlbut P, Wiegand SJ, Rudge J, Yancopoulos GD, Adamis AP, J Clin Invest 2002 109 805 815 11901189
29. Short-term variability in measures of glycemia and implications for the classification of diabetes. Selvin E, Crainiceanu CM, Brancati FL, Coresh J, Arch Intern Med 2007 167 1545 1551 10.1001/archinte.167.14.1545 17646610